• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma.

Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma. Ann Surg Oncol. 2010 Feb; 17(2):371-6.

View in: PubMed

subject areas
  • Adenocarcinoma
  • Adult
  • Aged
  • Antineoplastic Agents
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pancreatectomy
  • Pancreatic Neoplasms
  • Prospective Studies
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Risk Factors
  • Selection Bias
  • Survival Rate
  • Treatment Outcome

authors with profiles
  • David M. Mahvi